The other surprise that could come is an Omni-Car deal.
The likes of Johnson & Johnson have spent billions and years developing their CAR-T drug. So it's well worth them swinging $500m for a deal to use Omni-Car, to make their drug more effective, safer, controllable etc.
And then the floodgates open to other CAR-T pharmas who want to improve their drugs.
updated chart, page-7
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $36.23M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.5¢ | $40.19K | 861.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 275278 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 149532 | 2 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.6¢ |
Change
-0.002 ( 2.13 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 4.7¢ | 4.6¢ | 428792 | ||
| Last updated 14.48pm 21/05/2024 ? | |||||
| PTX (ASX) Chart |